C-Arms are imaging devices that work on the principles of X – ray technology. C-Arms have two key components: X – ray detector and X – ray source. C-Arms provide high resolution real time X – ray images, which help physicians monitor the surgery and make critical corrections where necessary and reduce the chances for follow up surgeries.
Global fluoroscopy and c-arm market is estimated to be valued at US$ 3,872.1 million in 2022 and is expected to exhibit a CAGR of 4.6% during the forecast period (2022-2030).
Figure 1. Global Fluoroscopy and C-Arm Market Share (%), by Product Type, 2022
Increasing product launch by the key market players to expand product portfolio is anticipated to propel the global fluoroscopy and c-arm market growth
Increasing product launch by the key market players to expand product portfolio is anticipated to propel the global fluoroscopy and c-arm market growth, over the forecast period. For instance, on November 16, 2021, FUJIFILM Holdings America Corporation, a diagnostic and enterprise imaging solutions company announced the launch of its compact mobile c-arm imaging system, the Persona CS mobile fluoroscopy system, which is intended for quick and smooth positioning in operating room and other environments. The robust and portable system is made to offer improved real-time image guiding for a variety of surgical operations including orthopaedic, difficult surgical, pain management (anaesthesia), and emergency procedures.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2021 | Market Size in 2022: | US$ 3,872.1 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: |
2022 to 2030 |
| Forecast Period 2022 to 2030 CAGR: | 4.6% | 2030 Value Projection: | US$ 5,552.2 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hologic, Inc., and Ziehm Imaging |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Global Fluoroscopy and C-Arm Market Share (%), by Region, 2022
Increasing adoption of fluoroscopy and c-arms is expected to propel growth of the global fluoroscopy and c-arms market.
Increasing adoption of fluoroscopy and c-arms is expected to propel growth of the global fluoroscopy and c-arms market over the forecast period. For instance, in November 2018, Agfa US Corp., a developer and manufacturer of imaging systems and IT solutions, was awarded a group purchasing agreement with Premier, which allowed Premier members, at their discretion, to take advantage, of special pricing and terms pre-negotiated by Premier for Agfa's comprehensive line of Direct Radiography (DR) systems.
Global Fluoroscopy and C-Arm Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
COVID-19 has affected the economy in three main ways: by directly affecting production and demand of medical devices, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another. Additionally, there were delays in hospitalization and surgical procedures as number of patient visits decreased, which affected the global fluoroscopy and c-arm market over the forecast period.
Global Fluoroscopy and C-Arm Market: Key Developments
On July 14, 2022, FUJIFILM Europe GmbH, a subsidiary of Fujifilm Holdings Corporation, Launched New Hybrid C-Arm and Portable X-Ray Device. Hybrid C-Arm and Portable X-ray machine planned to offer high quality fluoroscopic and static x-ray images during surgery and other medical procedures. The technology offers a more effective and streamlined workflow by capturing radiography and fluoroscopic images on a single platform.
Global Fluoroscopy and C-Arm Market: Restraint
Adoption of alternative techniques, to fluoroscopy is expected to hinder growth of the global fluoroscopy and c-arms market. Fluoroscopy techniques allow surgeons to perform minimally invasive surgical procedures. However, fluoroscopy involves risk from ionizing radiation due to which several physicians prefer use of alternative techniques such as ultrasound, which provides similar modalities. For instance, according to an article published in August, 2021, by Egyptian Journal of Radiology and Nuclear Medicine, ultrasound is the perfect initial imaging modality for imaging of urinary tract without ionizing radiation.
Key Players
Major players operating in the global Fluoroscopy and c-arm market include GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hologic, Inc., and Ziehm Imaging
Fluoroscopy is an imaging technique that uses X-ray technology for taking real-time images of the body, allowing physicians to visualize internal organs, muscles, and bones. Fluoroscopy devices use flat panel detectors for digital image processing that reduces the radiation dose administered to the patient. A fluoroscopy and C-Arm is a device used by physician to guide a needle to specific area with live X-ray screen. A fluoroscopy and C-Arm consist of two units, the image detector and X-ray generator on moveable C-Arm. Increasing prevalence of chronic diseases, new product approvals and launches along with increasing healthcare infrastructure during the forecast period is expected to assist the market growth.
Market Dynamics
Key market players are involved in inorganic growth activities such as partnership to increase product portfolio, is expected to drive the growth of global fluoroscopy and c-arm market, over the forecast period. For instance, on April 19, 2021, Ziehm Imaging GmbH, a developer, manufacturer of mobile X-ray-based imaging solutions, entered into a partnership with Carestream Health, a medical imaging company, announced the addition of a mobile C-Arm into its product portfolio. This surgical imaging system, the Ziehm Vision RFD C-Arm, will improve Carestream's mobile and fluoroscopic product. Moreover, increasing prevalence of musculoskeletal impairments in the world is expected to propel the growth of global fluoroscopy and c-arm market. For instance, according to data published on July 14, 2022, by the World Health Organization, around 1.71 billion people have musculoskeletal problems worldwide. Musculoskeletal impairments include more than 150 different diseases or conditions such as impairments in the muscles, bones, joints, etc. Musculoskeletal fluoroscopy is a nuclear radiology procedure used for detecting musculoskeletal abnormalities.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients